Evolus Correlations
EOLS Stock | USD 14.21 0.35 2.40% |
The current 90-days correlation between Evolus Inc and Collegium Pharmaceutical is 0.06 (i.e., Significant diversification). The correlation of Evolus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Evolus Correlation With Market
Average diversification
The correlation between Evolus Inc and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and DJI in the same portfolio, assuming nothing else is changed.
Evolus |
Moving together with Evolus Stock
0.85 | JNJ | Johnson Johnson | PairCorr |
0.78 | NKTX | Nkarta Inc | PairCorr |
0.75 | PDSB | PDS Biotechnology Corp | PairCorr |
0.69 | ABBV | AbbVie Inc Earnings Call Tomorrow | PairCorr |
0.7 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.83 | AMGN | Amgen Inc Earnings Call This Week | PairCorr |
0.72 | BDTX | Black Diamond Therap | PairCorr |
0.68 | DAWN | Day One Biopharmaceu | PairCorr |
0.66 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
0.76 | ACET | Adicet Bio | PairCorr |
Moving against Evolus Stock
0.4 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
0.33 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
0.69 | CDXS | Codexis | PairCorr |
0.34 | PTCT | PTC Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Evolus Stock performing well and Evolus Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evolus' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
COLL | 1.94 | (0.14) | 0.00 | (0.51) | 0.00 | 3.07 | 17.80 | |||
PAHC | 1.50 | (0.15) | 0.00 | (0.17) | 0.00 | 3.31 | 13.78 | |||
ANIP | 1.54 | (0.02) | (0.03) | 0.03 | 1.90 | 3.04 | 9.65 | |||
PROC | 10.54 | 1.02 | 0.09 | 2.97 | 10.71 | 38.04 | 122.49 | |||
SSIC | 1.01 | 0.18 | 0.12 | 0.66 | 0.80 | 3.36 | 8.15 | |||
EGRX | 3.94 | (1.12) | 0.00 | 1.19 | 0.00 | 9.24 | 53.71 | |||
DCPH | 1.66 | (0.21) | 0.00 | (1.68) | 0.00 | 3.27 | 9.66 | |||
PBH | 0.95 | 0.09 | 0.05 | 0.27 | 1.07 | 1.87 | 6.91 | |||
PCRX | 2.28 | 0.64 | 0.24 | 2.86 | 1.93 | 5.32 | 18.06 | |||
ITCI | 2.10 | 0.90 | 0.53 | (7.16) | 0.77 | 3.56 | 34.42 |
Evolus Corporate Management
Jessica Novak | Senior Resources | Profile | |
Tomoko YamagishiDressler | Chief Officer | Profile | |
CCFP DipSportMed | Chief RD | Profile | |
David Erickson | VP Relations | Profile |